Cargando…
Tanezumab: a selective humanized mAb for chronic lower back pain
Chronic lower back pain is a significant disease that affects nearly 20% of the worldwide population. Along with hindering patients’ quality of life, chronic lower back pain is considered to be the second most common cause of disability among Americans. Treating chronic lower back pain is often a ch...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825994/ https://www.ncbi.nlm.nih.gov/pubmed/29503555 http://dx.doi.org/10.2147/TCRM.S144125 |